ARCHIVES

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

This article is from The Cancer Letter archive.

Vol. 38 No. 16 | April 20, 2012

Download PDF Visit The Full Archive

Related Articles

Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists.

June 4, 2004

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

NCI Branch Chiefs, ACCI Join Support For DeVita

June 25, 1981

NCCN Publishes Anemia Guidelines

April 12, 2002

Clinical Trials Issues: Maryland Law Mandates Insurance Coverage Of Patient Care Costs In Clinical Trials

July 3, 1998

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009